Literature DB >> 24875081

Learning from exceptional drug responders.

Asher Mullard.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24875081     DOI: 10.1038/nrd4338

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  7 in total

1.  Biomarkers: exceptional responders-discovering predictive biomarkers.

Authors:  Naoko Takebe; Lisa McShane; Barbara Conley
Journal:  Nat Rev Clin Oncol       Date:  2015-02-17       Impact factor: 66.675

2.  RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?

Authors:  Guang Peng; Scott E Woodman; Gordon B Mills
Journal:  Cancer Discov       Date:  2014-09       Impact factor: 39.397

Review 3.  Envisioning the dynamics and flexibility of Mre11-Rad50-Nbs1 complex to decipher its roles in DNA replication and repair.

Authors:  Julien Lafrance-Vanasse; Gareth J Williams; John A Tainer
Journal:  Prog Biophys Mol Biol       Date:  2015-01-07       Impact factor: 3.667

Review 4.  Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?

Authors:  Veronique G LeBlanc; Marco A Marra
Journal:  Cancers (Basel)       Date:  2015-09-23       Impact factor: 6.639

5.  A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma.

Authors:  A K Mitra; T Harding; U K Mukherjee; J S Jang; Y Li; R HongZheng; J Jen; P Sonneveld; S Kumar; W M Kuehl; V Rajkumar; B Van Ness
Journal:  Blood Cancer J       Date:  2017-06-30       Impact factor: 11.037

6.  Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response.

Authors:  Clemens Grassberger; Kathryn Huber; Naduparambil K Jacob; Michael D Green; Peter Mahler; Joann Prisciandaro; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.102

Review 7.  Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.

Authors:  Ping-Pin Zheng; Jin Li; Johan M Kros
Journal:  Med Res Rev       Date:  2017-09-01       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.